Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection (Q44614118)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 March 2010

Language	Label	Description	Also known as
English	Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection	scientific article published on 5 March 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Stephen A McCartney

2

object named as

Stephen A McCartney

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Michael H Hühn

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Katharina Lind

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Emma Svedin

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Malin Flodström-Tullberg

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

5 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

401

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

42-48

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Protective role for interferon-beta in coxsackievirus B3 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Target cell defense prevents the development of diabetes after viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Interferons induce an antiviral state in human pancreatic islet cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

MDA-5 recognition of a murine norovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Detection of enteroviruses in the intestine of type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Type I interferons and the innate immune response--more than just antiviral cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Innate immunity to virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.02.010

7 January 2021

Identifiers

10.1016/J.VIROL.2010.02.010

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44614118&oldid=2029369518"